Evidence map›Paper›PMID 34353132›Full record

ArticleNew solutions : a journal of environmental and occupational health policy : NS2021

Answering a Call to Action on American Workplace and Community Opioid Concerns.

Peter Harnett, John Hindman, Melissa Duenas, Michael Coogan, Heather Misicko

Abstract read
In one paragraph

Article in New solutions : a journal of environmental and occupational health policy : NS, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Peter HarnettLeidos Inc., Reston, VA, USA.ORCID 0000-0002-0375-7880
John HindmanLeidos Inc., Reston, VA, USA.
Melissa DuenasLeidos Inc., Reston, VA, USA.
Michael CooganLeidos Inc., Reston, VA, USA.
Heather MisickoLeidos Inc., Reston, VA, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Leidos, Inc. is a large government science and technology company. When a Leidos employee lost his son to an opioid overdose, he wrote an impassioned email to the CEO, asking him to take action related to the growing societal problem of opioid use disorders. The CEO understood and accepted this important call to action. Leidos' subsequent efforts included supporting employees and families, as well as community outreach, eventually broadening to include mental health and well-being. This paper outlines the company's efforts to combat opioid use disorders, understanding that they sit within a larger total worker health umbrella inclusive of mental health and well-being. The hope is that this ongoing journey and its exemplars are helpful for other organizations seeking to make an impact for their employees and society.

Indexed as

Analgesics, OpioidWorkplaceHumansMaleMental HealthUnited StatesAnalgesics, Opioidemployee assistance programmental health wellnessopioid use disordersubstance use disordertotal worker health

Identifiers

PMID34353132
PMCPMC8505779

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.